Navigation Links
MAP Pharmaceuticals Announces Completion of LEVADEX™ Open-Label Safety Trial
Date:12/21/2010

to address undermet patient needs in neurology. The Company is developing LEVADEX orally inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of its Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.

Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

Forward-Looking StatementsIn addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to MAP Pharmaceuticals' LEVADEX product candidate. Actual results may differ materially from current expectations based on risks and uncertainties affecting the Company's business, including, without limitation, risks and uncertainties relating to the preparation and filing of a New Drug Application and the regulatory process to have the Company's LEVADEX product candidate approved for commercial use. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2010, available at http://edgar.sec.gov. CONTACTS: Nicole FoderaroWCG(415) 215-5643nfoderaro@wcgworld.com
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Bellicum Pharmaceuticals Announces $3 Million in Convertible Note Funding
2. Lotus Pharmaceuticals Announces Change of Directors
3. Poniard Pharmaceuticals Completes Voluntary Prepayment of Term Loans and Secures New Committed Equity Financing Facility
4. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
5. Optimer Pharmaceuticals Appoints Gregory Papaz to New Position of Senior Vice President of Commercial Operations
6. Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
7. John A. MacPhee Resigns From Strativa Pharmaceuticals
8. Poniard Pharmaceuticals Announces Plan for Voluntary Prepayment of Term Loan and Transfer to Nasdaq Capital Market
9. Savient Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
10. Amira Pharmaceuticals Announces the Nomination of an Orally Available Pre-Clinical Candidate in a New LPA-Related Program, an Autotaxin Inhibitor
11. Anthera Pharmaceuticals Selects the Merck BioManufacturing Network as Manufacturing Supplier for A-623, Antheras Investigational Novel Peptibody Agent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 Reaching a critical milestone ... National Association of Boards of Pharmacy ® (NABP ... domain suffix has passed the Internet Corporation for Assigned ... launch the .PHARMACY gTLD by the end of 2013, ... online pharmacies and related entities that are located in ...
(Date:5/21/2013)... , May 21, 2013 /PRNewswire/ ... VRX ) (TSX: VRX) ... directors nominated at its 2013 annual ... results of the vote for the ... below:  NameForWithheldRonald H. Farmer235,731,9341,964,748Robert A. Ingram233,865,8763,830,806Theo ...
(Date:5/21/2013)... TAUNTON, Massachusetts , 21 de mayo de 2013 ... Inc. ("OSI"), cuyas compañías filiales incluyen OMNIlife science®, ... dos directores experimentados para su junta. Guy Mayer, un ... directiva y David Johnson , ... como director. Antes de unirse a ...
Breaking Medicine Technology:NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 2NABP's .PHARMACY Proposal Passes Initial ICANN Evaluation 3Valeant Pharmaceuticals Announces 2013 Annual Meeting Results 2Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 2Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 3
... , STAMFORD, Conn., Nov. 13 ... it will be releasing a free trial version of its ... Sessions conference, taking place this November 15-17 in Orlando. Zargis ... of the companion hardware -- the 3M Littmann Electronic Stethoscope ...
... , , SILVER SPRING, Md., ... today approved Lysteda tablets (tranexamic acid), the first non-hormonal ... works by stabilizing a protein that helps blood to ... ) , Heavy menstrual bleeding is reported each year ...
Cached Medicine Technology:Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference 2Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference 3FDA Approves Lysteda to Treat Heavy Menstrual Bleeding 2
(Date:5/21/2013)... (PRWEB) May 21, 2013 Heritage Woods ... a BMA affordable assisted living community, is hosting a Quality ... Arthritis at 2 p.m. on Tuesday, May 28. , The ... Illinois, serves older adults of all incomes, including those on ... The Arthritis program is open to the public. There ...
(Date:5/21/2013)... Daily Gossip Magazine published well-documented articles that are meant to ... on the latest weight loss methods by publishing weekly in-depth ... review of Kyle Leon’s Customized Fat Loss Plan ... lose weight or stay in shape with the minimum effort. ... by a popular fitness trainer, Kyle Leon, who has made ...
(Date:5/21/2013)... Parker Waichman LLP, a national law firm dedicated ... devices, is offering remarks on the closing argument of the ... E. Taylor v. Intuitive Surgical, 09-2-03136-5, Superior Court, State of ... Bloomberg report noted that the plaintiff’s attorney, after noting ... how it deployed its strategy to train doctors to use ...
(Date:5/21/2013)... 21, 2013 Parker Waichman LLP, a ... victims injured by defective medical devices, is addressing new ... Surgery on May 15, 2013. The study found that ... complications that occur in patients with metal-on-metal hip implants ... http://www.jbjs.org/article.aspx?articleid=1684770 ) , “We’ve known for ...
(Date:5/21/2013)... 2013, Paris, France: One-year results from SOURCE XT ... (TAVI) registries to-date reported today at EuroPCR 2013 ... high rates of device success for all access approaches, ... Post-Approval Study followed up 2688 consecutively enrolled patients (mean ... heart valve at 93 centres in 17 countries between ...
Breaking Medicine News(10 mins):Health News:Heritage Woods of Dwight Affordable Assisted Living to Host Informational Program on the Do's and Don'ts of Arthritis 2Health News:Customized Fat Loss Plan Review and Diet Secrets Revealed By Daily Gossip Magazine 2Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 2Health News:Da Vinci Robotic Surgery Lawsuit: Parker Waichman LLP Reacts to Plaintiff’s Attorney’s Closing Argument in Which He Describes Intuitive Surgical as a Car Dealership 3Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3
... brought out its version of bird flu, a blur of fact ... ,"Fatal Contact: Bird Flu in America," an ABC made-for-television movie, airs ... birds in Alaska that could herald the arrival of bird flu ... so it could be passed from human to human, sparking a ...
... that India is planning to start an exercise to ... HIV// and need anti-HIV therapy to extend their lives. ... and Indian paediatricians are starting to work on trying ... and provide training to medical professionals in diagnosis and ...
... fee structure in private medical & paramedical colleges was hoped ... T.N. Chaturvedi having signed the CET bill//. But it has ... private medical colleges and the state government has surfaced yet ... now looking at the Supreme Court to come to their ...
... a charge on cancer patients for powerful, intravenous medications, ... seriously considered by Ontario's Health Minister. ,George Smitherman ... due diligence and obviously we're closer to having a ... right thing said in a telephone interview yesterday. I ...
... Association has released a set of new recommendations and ... in the rapid access issue of Stroke: Journal of ... leading cause of death and a major source of ... people in the United States suffer a stroke, resulting ...
... An interesting study conducted by The Royal College of Midwives ... out of the labor room//. Nearly 38% of the 1400 ... the delivery room. ,Surprisingly, one in four fathers ... useless during the birth process while one in six mothers ...
Cached Medicine News:Health News:Bird Flu: Fact or Fiction 2Health News:Bird Flu: Fact or Fiction 3Health News:India To Estimate The Number Of Children Infected With HIV/AIDS 2Health News:How To Prevent A Stroke 2Health News:How To Prevent A Stroke 3Health News:How To Prevent A Stroke 4
... an affordable path to Sonesta flexibility. ... and back adjustments. Packaged with basic ... line of Sonesta add-ons, allowing you ... your needs; complete Sonesta flexibility at ...
... easy patient positioning and access. Mounting ... be rotated up to 90 degrees ... a moveable accessory tray to facilitate ... other devices in fixed relationship to ...
For complete unobstructed imaging coverage for a wide range of urological procedures, HealthTronics urodynamics Chair/Table is the answer....
... serum bilirubin levels with no pain, no ... to the traditional heel stick method or ... levels without regard to gender, gestational age ... touches the babys forehead, which reduces the ...
Medicine Products: